lobbying_activities: 2503881
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2503881 | 25bcf25e-e2fc-47a9-afb4-e1074837f16b | Q3 | HOLLAND & KNIGHT LLP | 18466 | VIATRIS INC | 2020 | third_quarter | PHA | Drug shortages, formulary tiering, National Defense Authorization Act (NDAA), biosimilar uptake, Medicare generics penalty, generic drugs, supply chain. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2020-10-05T10:52:24.070000-04:00 |